Business Description
Indivior PLC
ISIN : GB00BN4HT335
Share Class Description:
STU:2IVB: Ordinary ShareDescription
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.35 | |||||
| Equity-to-Asset | -0.08 | |||||
| Debt-to-Equity | -2.32 | |||||
| Debt-to-EBITDA | -2.55 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 1.75 | |||||
| Beneish M-Score | -2.14 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 24.9 | |||||
| 3-Year EPS without NRI Growth Rate | 60.8 | |||||
| 3-Year FCF Growth Rate | -29.1 | |||||
| 3-Year Book Growth Rate | 164.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 16.34 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 5.85 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.66 | |||||
| 9-Day RSI | 27.34 | |||||
| 14-Day RSI | 29.32 | |||||
| 6-1 Month Momentum % | -41.02 | |||||
| 12-1 Month Momentum % | -44.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.85 | |||||
| Quick Ratio | 0.68 | |||||
| Cash Ratio | 0.37 | |||||
| Days Inventory | 231.93 | |||||
| Days Sales Outstanding | 78.67 | |||||
| Days Payable | 77.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 2.4 | |||||
| Shareholder Yield % | 6.54 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 79.45 | |||||
| Operating Margin % | -17.1 | |||||
| Net Margin % | -12.49 | |||||
| FCF Margin % | -24.03 | |||||
| ROE % | -54.76 | |||||
| ROA % | -8.4 | |||||
| ROIC % | -8.76 | |||||
| 3-Year ROIIC % | 10.47 | |||||
| ROC (Joel Greenblatt) % | -156.03 | |||||
| ROCE % | -25.35 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 6.5 | |||||
| PE Ratio without NRI | 5.79 | |||||
| Shiller PE Ratio | 13.25 | |||||
| PS Ratio | 1.12 | |||||
| EV-to-EBIT | -6.92 | |||||
| EV-to-EBITDA | -10.07 | |||||
| EV-to-Revenue | 0.96 | |||||
| EV-to-FCF | -3.95 | |||||
| Price-to-Projected-FCF | 8.14 | |||||
| Price-to-Median-PS-Value | 0.5 | |||||
| Earnings Yield (Greenblatt) % | -14.45 | |||||
| FCF Yield % | -23.33 | |||||
| Forward Rate of Return (Yacktman) % | 7.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Indivior PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,061.659 | ||
| EPS (TTM) (€) | -0.991 | ||
| Beta | 0.31 | ||
| Volatility % | 47.58 | ||
| 14-Day RSI | 29.32 | ||
| 14-Day ATR (€) | 0.359041 | ||
| 20-Day SMA (€) | 10.0275 | ||
| 12-1 Month Momentum % | -44.78 | ||
| 52-Week Range (€) | 8.35 - 20.7 | ||
| Shares Outstanding (Mil) | 130.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Indivior PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Indivior PLC Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Indivior PLC Frequently Asked Questions
What is Indivior PLC(STU:2IVB)'s stock price today?
The current price of STU:2IVB is €8.55. The 52 week high of STU:2IVB is €20.70 and 52 week low is €8.35.
When is next earnings date of Indivior PLC(STU:2IVB)?
The next earnings date of Indivior PLC(STU:2IVB) is 2024-11-08 Est..
Does Indivior PLC(STU:2IVB) pay dividends? If so, how much?
Indivior PLC(STU:2IVB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers